Annamycin anthracycline data

ARNX presented Phase I results in cancer patients who had failed other therapies.

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE